Onconetix provides up to USD 5 million non-interest bridge loan to Realbotix LLC
ONCO•Terms of the facility
The facility is non-interest bearing until the share exchange closes, and it is automatically cancelled and discharged at closing.
Cash required at closing will be reduced by the principal advanced under the facility, plus an additional $500,000.
If the share exchange is terminated, interest accrues at 12% per year from the termination date.
Bridge financing facility for Realbotix
Onconetix opened a strategic bridge financing facility of up to $5 million for Realbotix, its pending acquisition target.
$2.5 million was advanced at signing to fund growth initiatives and working capital needs.
